Good morning everyone
I have a bit of a dilemma and would be very grateful for any advice from the wonderful members here - sorry, it seems that I'm forever asking for help!
Currently I'm on dasatinib 100mg, but I'm having a single, frightening side effect: rapidly enlarging lymph nodes on the right hand side of my neck. One is so large it is clearly visible and stands out quite some distance from my neck. The haematologist has monitored this carefully and has tested for all sorts of other conditions, including lymphoma, and all is negative. Consequently I am changing to imatinib on 1 May.
This would ordinarily be fine, except that my latest PCR test has shown a slight rise in BCR-Abl from 0.05% to 0.08%. I am a very slow responder and took two years to reach MMR, and now the increase concerns me - even though 0.03 doesn't look like a lot, it is a 60% increase. My question is whether I should push to be changed to nilotinib instead of imatinib? I am not keen on the fasting regime associated with nilotinib, but I am worried that the imatinib isn't strong enough to maintain my BCR-Abl at such a low level.
Any advice would be greatly appreciated!
Thank you so much to everyone on this site. Without you, I think I would be neurotic with worry.
Best wishes
Martin